Skip to main content

Table 1 IHC scoring for LIMK1 expression and nuclear localization

From: Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression

LIMK1 staining by IHC Normal
(67 samples)
Breast Cancer
(84 samples)
Strong Cytoplasmic* 48% 76%
Nuclear staining in those with strong cytoplasmic LIMK1+ 27% (13%) 52% (39%)
  1. *Percent of total
  2. + Percent of subset with strong cytoplasmic staining; (% of total)